AI Insight
A Phase III randomized trial (SWOG S1827 MAVERICK) found that small-cell lung cancer patients who received regular brain MRI surveillance instead of prophylactic cranial irradiation had significantly better cognitive failure-free survival, which was the study's primary endpoint. Overall survival rates appeared similar between the two approaches, suggesting that monitoring with MRI may preserve cognitive function without compromising longevity.
Why it matters
This finding could change clinical practice for small-cell lung cancer treatment by offering patients a way to avoid cognitive decline associated with preventive brain radiation while maintaining survival outcomes. The approach provides a less invasive surveillance alternative that prioritizes quality of life and cognitive preservation.
In the SWOG S1827 MAVERICK Phase III randomized trial, patients with small-cell lung cancer (SCLC) who underwent regular brain MRI surveillance without prophylactic cranial irradiation (PCI) had significantly better cognitive failure-free survival (the primary endpoint of the trial), without an apparent difference in overall survival, according to results presented at the Presidential Symposium of the IASLC 2026 World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer, in Seoul, South Korea.